Phase III trial of doxorubicin plus cyclophosphamide (AC), docetaxel, and alternating AC and docetaxel as front-line chemotherapy for metastatic breast cancer: Japan Clinical Oncology Group trial (JCOG9802)
Title:
Phase III trial of doxorubicin plus cyclophosphamide (AC), docetaxel, and alternating AC and docetaxel as front-line chemotherapy for metastatic breast cancer: Japan Clinical Oncology Group trial (JCOG9802)
Author:
Katsumata, N. Watanabe, T. Minami, H. Aogi, K. Tabei, T. Sano, M. Masuda, N. Andoh, J. Ikeda, T. Shibata, T. Takashima, S.